Tempus AI held its IPO in June 2024 and is applying AI solutions to healthcare. Investors should watch several metrics to assess the company's growth prospects. While Tempus AI could reap big ...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has acquired Deep 6 AI ...

Tempus AI is seeing strong growth as companies remain interested in the AI industry. Its annual revenue has jumped from $62.1 million in 2019 to over $531 million in the last financial year.

Tempus AI (NASDAQ:TEM) delivered a very mixed Q4 2024 earnings report that saw its shares sell off about 15% after hours. The main takeaway here is that Tempus' core business is expected to grow ...

Tempus AI, Inc. TEM reported fourth-quarter 2024 adjusted loss per share of 18 cents, which missed the Zacks Consensus Estimate of a loss of 15 cents by 16.7%. GAAP loss per share was 8 cents.

Tempus AI TEM, an innovator in artificial intelligence-based healthcare solutions, has been attracting investors' interest since its successful IPO in June 2024. The stock had been on a strong ...

Tempus AI reports fourth-quarter revenue of $200.68 million, missing estimates of $203.12 million. Tempus reports a fourth-quarter adjusted loss of 18 cents per share, beating analyst estimates ...

Tempus AI stock faces mixed signals ahead of Q4 earnings, with short-term bearish pressure but technical support. Analysts see a 13.5% downside for Tempus AI, while technical indicators suggest ...

Skyrocketing 108% since the start of 2025, Tempus AI (NASDAQ: TEM), a company applying AI solutions to healthcare, has seen its stock perform exceptionally well this year. Investors have found the ...